Wesper reinvents sleep medicine with a fully digital at-home sleep lab solution.
We created the first longitudinal and wireless clinical-grade sleep testing platform designed to increase your clinic's efficiency and get your patients the care they need. With 95.1% correlation to a sleep lab, the FDA-cleared device is eligible for reimbursement and measures sleep position, snoring, oxygen desaturation, apnea events, breathing quality, pulse rate, and much more.
We created the first longitudinal and wireless clinical-grade sleep testing platform designed to increase your clinic's efficiency and get your patients the care they need. With 95.1% correlation to a sleep lab, the FDA-cleared device is eligible for reimbursement and measures sleep position, snoring, oxygen desaturation, apnea events, breathing quality, pulse rate, and much more.
Location: United States, New York
Employees: 11-50
Phone: +1 575-448-2824
Total raised: $9.6M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | Flok Ventu... | flok.ventu... |
| 24.11.2022 | Krillion V... | krillionve... |
| - | Endless Fr... | endlessfro... |
| - | Spark Capi... | sparkcapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.11.2022 | Series A | $9.6M | - |
Mentions in press and media 5
| Date | Title | Description |
| 15.05.2025 | Wesper (Life Sciences, '19-20) is Rewriting Sleep Apnea Diagnosis: The FDA-Cleared Tech That Replaces Cannulas with Comfort | - |
| 22.11.2022 | Wesper Raises $9.6M in Series A Funding | Wesper, a New York-based clinical-grade FDA-cleared wireless home sleep lab company, raised $9.6M in Series A funding. Backers included Valor Equity Partners, Breyer Capital, and Spark Capital. The company intends to use the funds to accele... |
| 21.11.2022 | At-home sleep lab provider Wesper raises $9.6M | The platform can measure inconsistent breathing throughout the night I have sleep apena, and when I had to get my diagnosis it involved going to a sleep lab two times: once to determine if I had sleep apnea in the first place, and then agai... |
| 09.11.2022 | Wesper Raises $7.5M in Series A Funding | Wesper, a NYC-based provider of a clinical-grade FDA cleared platform to bring the full cycle of sleep therapy to home users, raised $7.5M in Series A funding. The round was led by Ceros Capital Markets. The company intends to use the funds... |
| - | Wesper | “The first at-home sleep study with professional guidance. From mild symptoms to sleep apnea, get started sleeping better today.” |